The company held the fourth session of the 11th board of directors and the fourth session of the 10th board of supervisors to examine and approve the 2021 semi-annual report and other motions.
Release time:
2021-09-13
News from our newspaper # February 27 , the company held the fourth meeting of the 11th board of directors to review and approve 2021 semi-annual report and its summary, the proposal on the disposal of assets by the holding subsidiary, the proposal on the appointment of the director of the audit office, the proposal on the related party transaction proposal on the signing of the framework agreement on the equity restructuring of the participating subsidiary and other 4 related reports and proposals.
2021# In the first half of the year, the company focused on the general policy of "following the law, keeping the right and bringing forth the new, changing and innovating, and continuously improving", on the basis of risk prevention and control, optimize the management system, improve operational efficiency, and maintain the smooth operation of the company. In the first half of the year, the company realized operating income17.13 .3 billion yuan, net profit 3.20 .5 billion yuan attributable to shareholders, and earnings per share 0.93 yuan. As of the end of 2021 6 , the company's total assets were 61.98 .3 billion yuan, the net assets attributable to shareholders of listed companies were 46.12 .5 billion yuan, and the net assets per share were 13.40 yuan.
Cement Plate: While doing a good job in epidemic prevention and control, the cement enterprises under the company actively carry out benchmarking management and standardized management internally, continuously promote the "three reductions and three improvements" activities, strictly control production costs, steadily implement various technological transformation work, and improve the production efficiency of enterprises; timely understand market trends externally, accurately study and judge market trends, and improve sales management mode. Daye Peak has completed more than 10 technical renovation projects such as low nitrogen combustion renovation at kiln end, dust collection system renovation at kiln end, and oil station renovation of cement mill roller press, effectively reducing consumption, improving system operation rate and reducing potential environmental protection and safety hazards. Facing the market changes, the marketing strategy was adjusted in time, and the production and sales were organized in an orderly manner under the guidance of market demand. Cement sales reached a record high. Yunnan Jianfeng strictly controls the procurement cost of raw materials by strengthening bidding management and continuously tracking the dynamic price information of purchased materials; in accordance with the requirements of the quality management system, it strengthens the quality control of raw materials and semi-finished products to ensure the quality of cement factory. Relying on the advanced second-generation new dry-process cement production line and adopting digital intelligent control technology, Guizhou Huangping Jianfeng carries out all-round intelligent management of safe production, product quality, material consumption and energy consumption, environmental protection emissions, etc. Since its commissioning, various economic indicators such as standard coal consumption, electricity consumption, operation rate and kiln time production have all reached expectations. Completed the transformation of cement large packaging, frequency conversion transformation of water diversion project and other projects, and achieved results in efficiency improvement; facing the challenges of weak investment and overcapacity in the regional market, we have increased investment in brand promotion in the terminal market and further increased the share of the core market.Pharmaceutical sector: Peak pharmaceutical products won the first bid for the national centralized procurement of drugs, olopatadine hydrochloride eye drops won the bid for the fourth batch of national centralized procurement of drugs, which is conducive to improving the market share of the product. In the first half of the year, Jianfeng Pharmaceutical and its subsidiaries made progress in a number of technological innovations and engineering constructions. The construction of the annual output of
20 .5 billion solid preparations (internationalization) project in Jinxi Production Base of Jianfeng Pharmaceutical was carried out in an orderly manner. At present, the civil engineering, mechanical and electrical installation and equipment installation and commissioning of the main project have been basically completed, and the verification and confirmation of process equipment and public system equipment and the construction of the project quality system are being carried out; new North Card and Peak North Card continue to fully implement technological transformation, upgrade on the basis of their existing pesticides and pharmaceutical intermediates, build a comprehensive research and development and production base for APIs, pharmaceutical intermediates and pesticides, and actively promote the industrial upgrading strategy of the integration of Peak Pharmaceutical APIs and preparations. Relying on the existing research and development platform and production base, Jianfeng Pharmaceutical Co., Ltd. gives full play to the enthusiasm of research and development personnel and speeds up the research and development progress of varieties under research. At present, more than 20 projects under research are in various stages of preclinical, clinical, pilot test, production declaration and consistency evaluation, and 2 projects are in Phase I clinical trials, 3 items in consistency evaluation; 2 items have been declared for production. Spike Pharmaceuticals also continues to explore new marketing business models, a comprehensive combing of product flow, and strengthen channel control.
Other sectors: Under the influence of the new coronary pneumonia epidemic, the national health care awareness is increasing, the demand for health products is gradually recovering, the peak health market expansion has achieved results, and the sales volume of health products has increased; Tianjin Peak Natural Products Company has reformed and optimized its product process, further reducing production costs while improving production capacity. Peak International Trade Phase III modern warehousing expansion project was fully delivered, warehousing and logistics business volume increased steadily, Jinhua South Station warehousing and transportation advantages into full play, warehousing and operation capacity has been improved. Peak cable by seizing the subway cable demand growth opportunities, strengthen communication with industry associations to improve visibility, to achieve revenue growth.On the same day, the company also held the fourth meeting of the tenth board of supervisors, and reviewed and approved the company's
2021semi-annual report and its summary and the related transaction proposal on the signing of a framework agreement for the reorganization of equity participation in subsidiaries. (residual fruit
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11